HUMAN TISSUE INTENDED FOR TRANSPLANTATION -- 21 CFR 1270

Forms and Documents

Document Name	Status

No forms / supporting documents in this ICR. Check IC Document Collections.

IC Document Collections

IC ID	Document Title	Status
110008	HUMAN TISSUE INTENDED FOR TRANSPLANTATION -- 21 CFR 1270	Migrated

ICR Details

OMB Control No: 0910-0302	ICR Reference No: 199403-0910-002
Status: Historical Active	Previous ICR Reference No:
Agency/Subagency: HHS/FDA	Agency Tracking No:
Title: HUMAN TISSUE INTENDED FOR TRANSPLANTATION -- 21 CFR 1270
Type of Information Collection: New collection (Request for a new OMB Control Number)	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 06/08/1994
	Date Received in OIRA: 03/11/1994
Terms of Clearance: We have approved the information collection requirements contained in the interim final rule published on December 14, 1993 with the followi condition. We have approved the collection for less than the maximum three-year period allowed under the Paperwork Reduction Act because th interim final rule was promulgated without affording the public an opportunity to comment on the information collection requirements contained in the rule. In developing the proposed revisions to the interim final rule that it has promised, FDA should carefully consider the results of the tissue bank survey it is currently conducting. FDA should use the survey to assess the current voluntary industry standar and practices for ensuring the safety of tissue intended for trans- planatation and be able to demonstrate that the additional information collection requirements contained in the interim final regulation are the least burdensome necessary and that they have practical utility. Finally, we note that the agency violated the Paperwork Reduction Act by failing to submit the information collection requirements contained in the interim final rule until three months after the promulgation of the rule. (See 5 CFR 1320.13).

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	08/31/1995	08/31/1995
Responses	400	0	0
Time Burden (Hours)	4,616	0	0
Cost Burden (Dollars)	0	0	0

---

Abstract: FDA ISSUED AN INTERIM RULE REQUIRING CERTAIN INFECTIOUS DISEASE TESTING, DONOR SCREENING, AND RECORDKEEPING TO HELP PREVENT THE TRANSMISSION OF AIDS AND HEPATITIS THROUGH HUMAN TISSUE USED IN TRANSPLANTATION.

---

Authorizing Statute(s): None

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:

---

Federal Register Notices & Comments

Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
HUMAN TISSUE INTENDED FOR TRANSPLANTATION -- 21 CFR 1270

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	400	0	0	400	0	0
Annual Time Burden (Hours)	4,616	0	0	4,616	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $0

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? Uncollected

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 03/11/1994

---